Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 91%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
90,531
Total Claims
$2.9M
Drug Cost
533
Beneficiaries
$5,416
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-79%
Opioid rate vs peers
0.5% vs 2.6% avg
+407%
Cost per patient vs peers
$5,416 vs $1,068 avg
-19%
Brand preference vs peers
7.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.5%
Opioid Rate
488
Opioid Claims
$16K
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 6,610 claims · $2.0M
Generic: 83,892 claims · $845K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,816 | $290K |
| Pimavanserin Tartrate | 99 | $149K |
| Dulaglutide | 116 | $115K |
| Dextromethorphan Hbr/Quinidine | 290 | $110K |
| Adalimumab | 12 | $88K |
| Bictegrav/Emtricit/Tenofov Ala | 20 | $80K |
| Deutetrabenazine | 86 | $74K |
| Rivaroxaban | 482 | $64K |
| Insulin Glargine,hum.Rec.Anlog | 134 | $57K |
| Dolutegravir Sodium | 96 | $50K |
| Mirabegron | 295 | $46K |
| Emtricitabine/Tenofov Alafenam | 20 | $46K |
| Collagenase Clostridium Hist. | 39 | $39K |
| Insulin Aspart | 119 | $38K |
| Risperidone Microspheres | 41 | $37K |
Prescribing Profile
Patient Profile
76
Avg Age
65%
Female
2.56
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About